|
Gomez RL, Ibragimova S, Ramachandran R, Philpott A, Ali FR |
Tumoral heterogeneity in neuroblastoma |
Saturday, September 24, 2022 |
Biochim Biophys Acta Rev Cancer |
|
V. Chell;K. Balmanno;A. S. Little;M. Wilson;S. Andrews;L. Blockley;M. Hamps... |
Tumour cell responses to new fibroblast growth factor receptor tyrosine kin... |
|
Oncogene |
|
Abdulla S, Saada J, Johnson G, Jefferies S, Ajithkumar T |
Tumour progression or pseudoprogression? A review of post-treatment radiolo... |
Saturday, August 15, 2015 |
Clinical radiology |
|
Olubajo F, Thorpe A, Davis C, Sinha R, Crofton A, Mills SJ, Williams M, Jen... |
Tumour treating fields in glioblastoma: is the treatment tolerable, effecti... |
Thursday, February 24, 2022 |
Br J Neurosurg |
|
Gatfield ER1, Noble DJ2, Barnett GC3, Early NY4, Hoole ACF4, Kirkby NF5, Je... |
Tumour Volume and Dose Influence Outcome after Surgery and High-dose Photon... |
Monday, April 30, 2018 |
Clin Oncol (R Coll Radiol) |
|
Mandal AS, Wiener C, Assem M, Romero-Garcia R, Coelho P, McDonald A, Woodbe... |
Tumour-infiltrated cortex participates in large-scale cognitive circuits |
Tuesday, January 30, 2024 |
Cortex |
|
Giuriato S, Turner SD |
Twenty years of modelling NPM-ALK-induced lymphomagenesis |
Tuesday, May 12, 2015 |
Frontiers in bioscience (Scholar edition) |
|
Lawson MH, Cummings NM, Rassl DM, Russell R, Brenton JD, Rintoul RC, Murphy... |
Two novel determinants of etoposide resistance in small cell lung cancer |
|
Cancer Research |
|
Nambiar PR, Morton D, Dochterman LW, Houle C, Thomford PJ, Fate G, et al. |
Two-year carcinogenicity study in rats with a nonnucleoside reverse transcr... |
Friday, August 15, 2014 |
Toxicologic pathology |
|
Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale ... |
Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in... |
Thursday, December 4, 2014 |
The lancet Diabetes & endocrinology |
